Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Isenman

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1995
Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertaseR O Ebanks, D E Isenman
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4D E Isenman, J R Young
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1994
Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chainA Taniguchi-Sidle, D E Isenman
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2R J Diefenbach, D E Isenman
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1986
Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfacesD E Isenman, J R Young
The Journal of Biological Chemistry|February 13, 1999
Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35)A E Oran, D E Isenman
Biochemistry|July 24, 1979
Folding pathways of immunoglobulin domains. The folding kinetics of the Cgamma3 domain of human IgG1D E Isenman, D Lancet, I Pecht
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 bindingQ Pan, R O Ebanks, D E Isenman
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1975
The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complementD E Isenman, K J Dorrington, R H Painter
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1980
The effects of mild reduction on the structure and function of C3D E Isenman, J S Sundsmo, N R Cooper
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1995
Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertaseR O Ebanks, D E Isenman
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4D E Isenman, J R Young
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1994
Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chainA Taniguchi-Sidle, D E Isenman
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2R J Diefenbach, D E Isenman
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1986
Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfacesD E Isenman, J R Young
The Journal of Biological Chemistry|February 13, 1999
Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35)A E Oran, D E Isenman
Biochemistry|July 24, 1979
Folding pathways of immunoglobulin domains. The folding kinetics of the Cgamma3 domain of human IgG1D E Isenman, D Lancet, I Pecht
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 bindingQ Pan, R O Ebanks, D E Isenman
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1975
The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complementD E Isenman, K J Dorrington, R H Painter
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1980
The effects of mild reduction on the structure and function of C3D E Isenman, J S Sundsmo, N R Cooper
Pageof 5